首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺表面活性物质对不同胎龄呼吸窘迫综合征新生儿的疗效
引用本文:陈飒英,蓬蕊,杨凌,王琨蒂,郑承宁.肺表面活性物质对不同胎龄呼吸窘迫综合征新生儿的疗效[J].实用儿科临床杂志,2011,26(14):1099-1100,1107.
作者姓名:陈飒英  蓬蕊  杨凌  王琨蒂  郑承宁
作者单位:中日友好医院,儿科,北京,100029
摘    要:目的 探讨肺表面活性物质(PS)对不同胎龄儿呼吸窘迫综合征(RDS)的疗效差异.方法 选择胎龄28~39周,出生体质量760~3 240 g,经PS治疗的RDS患儿67例.早期组:胎龄28~30周的早期早产儿18例;中期组:胎龄31~33周的中期早产儿28例;晚期组:胎龄34周以上的晚期早产儿和足月儿21例.比较3组PS治疗时RDS的重症程度、PS开始使用时间、第1次使用剂量、总剂量、重复使用例数、氧疗时间、最高吸氧体积分数(FiO2)、机械通气时间等指标.结果 PS治疗时早期组和中期组轻度RDS例数明显多于晚期组(Pa<0.05).中期组和晚期组重度RDS例数明显多于早期组(Pa<0.05),PS开始使用时间晚期组明显晚于早、中期组(Pa<0.05).第1次使用剂量早期组明显多于中、晚期组(Pa<0.05).使用总剂量和重复使用例数各组间均无统计学差异(Pa>0.05).机械通气时间早、晚期组明显多于中期组(P=0.040);最高FiO2以晚期组最高(P=0.006).结论 早期早产儿RDS病情轻、开始PS治疗时间早、剂量足,但需氧疗和机械通气时间长;晚期早产儿和足月儿RDS病情危重、开始PS治疗时间晚、剂量不足、需氧疗和机械通气时间长.对晚期早产儿和足月儿RDS治疗应尽早、足量使用PS.

关 键 词:呼吸窘迫综合征  肺表面活性物质  不同胎龄儿

Effect of Pulmonary Surfactant Therapy on Infants with Respiratory Distress Syndrome at Different Gestational Ages
CHEN Sa-ying , PENG Rui , YANG Ling , WANG Kun-di , ZHENG Cheng-ning.Effect of Pulmonary Surfactant Therapy on Infants with Respiratory Distress Syndrome at Different Gestational Ages[J].Journal of Applied Clinical Pediatrics,2011,26(14):1099-1100,1107.
Authors:CHEN Sa-ying  PENG Rui  YANG Ling  WANG Kun-di  ZHENG Cheng-ning
Institution:(Department of Pediatrics,China-Japan Friendship Hospital,Beijing 100029,China)
Abstract:Objective To explore the difference of effect of pulmonary surfactant(PS) therapy on infants with respiratory distress syndrome(RDS)at different gestational ages.Methods Sixty-seven cases of PS-treated RDS infants at gestational age 28-39 weeks and with birth weight 760-3 240 g were recruited.Early group:18 cases of preterm infants at gestational age 28-30 weeks;medium group:28 cases of preterm infants at gestational age 31-33 weeks;late group:21 cases of either preterm infants at gestational age over 34 weeks or full term infants.Severity of RDS while starting PS therapy,the time of starting PS treatment,the initial dose,re-doses,total dose,the duration of oxygen therapy,the maximum inspired oxygen fraction(FiO2) and mechanical ventilation time were compared among these groups.Results The number of mild RDS cases in early and medium group treated with PS were significantly more than that in the late group(Pa<0.05),whereas the number of severe RDS cases in medium and late group treated with PS were significantly more than that in the early group(Pa<0.05).The time of starting PS treatment was later in late group than that in the early group and medium group.The starting dose of PS applied to early group was significantly higher than that in the medium group and late group(P<0.05).There were no difference in re-dose and total dose among all 3 groups(Pa>0.05).The mechanical ventilation time was longer in the early group and late group(P=0.040);but the maximum FiO2 value was found in the late group(P=0.006).Conclusions Early preterm RDS treated with PS are clinically mild,treated earlier at adequate dosage,and they need longer time on oxygen therapy and mechanical ventilation;which late preterm and full term RDS are more clinically severe,treated with PS later and at inadequate dosage,and they also need longer duration on oxygen therapy and mechanical ventilation.PS shall be used earlier,with adequate dosage in late preterm and full term infants.
Keywords:respiratory distress syndrome  pulmonary surfactant  different gestational age
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号